# ATS 3f(r) Aortic Bioprosthesis Model 1000 Post Approval Study

> **NCT01116037** · NA · TERMINATED · sponsor: **Medtronic Cardiovascular** · enrollment: 26 (actual)

## Conditions studied

- Heart Valve Diseases

## Interventions

- **DEVICE:** ATS 3f Aortic Bioprosthesis

## Key facts

- **NCT ID:** NCT01116037
- **Lead sponsor:** Medtronic Cardiovascular
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-09
- **Primary completion:** 2015-11
- **Final completion:** 2015-11
- **Target enrollment:** 26 (ACTUAL)
- **Why stopped:** Business decision to end study due to limited enrollment and study population
- **Last updated:** 2017-05-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01116037

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01116037, "ATS 3f(r) Aortic Bioprosthesis Model 1000 Post Approval Study". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01116037. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*